The Lilly GI Team is excited to attend AIBD 2024 in Orlando, FL! Visit Lilly Medical at Booth 516, where our team will be available to answer your questions. View the schedule here: https://e.lilly/3UIZIzY #InflammatoryBowelDisease
关于我们
Lilly’s official US support channel for medical news, information, and education. Content is intended for US HCPs. General Information and Guidelines: Eli Lilly and Company strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse. When you engage with Lilly on LinkedIn (and any other of Lilly’s social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn: https://e.lilly/guidelines If you have any questions about a Lilly therapy or medicine, please contact our customer care line at 1-800-LillyRx (1-800-545-5979) Monday through Friday in the U.S., excluding holidays.
- 网站
-
https://www.lillymedical.com
Lilly Medical US的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Indianapolis，Indiana
- 领域
- Lilly Medical Affairs
动态
-
Lilly Medical is proud to stand alongside healthcare professionals making meaningful progress for people with #diabetes! Thank you to our dedicated #HCPs for being true champions of care and hope. Together, we are making a real difference in the lives of patients around the world. Learn More: https://e.lilly/3CHM4H4
-
New Publication! Explore the latest science in #Obesity from the SURMOUNT-1 Phase 3 trial, now available in the New England Journal of Medicine. Read the results in NEJM: https://e.lilly/3Z45XRm
-
-
??We’re excited to share that HCPs can now find our #CLL educational content on YouTube! Hear expert insights and explore short educational topics designed to fuel your learning journey and keep you current with advancements in HCP decision making and patient care. #LeuSM #LymSM ??Watch and subscribe here: https://e.lilly/4feMQd2
-
New Publication in Neurology and Therapy: Factors and Reasons Associated with Hesitating to Seek Care for Migraine. To explore the results of the OVERCOME (US) Study, read the full publication here: https://e.lilly/3Z2a66Y
-
-
Lilly Medical thanks you for joining us at #ACR2024! Hear what Lilly's Sr. Vice President of Immunology Global Medical Affairs, Anabela Cardoso MD, has to say about their experience! Stay connected to the latest science - click here to learn more: https://e.lilly/4fY1TYv
-
-
NEW PUBLICATION: Efficacy & safety results from the VIVID-1 Phase 3 study evaluating patients with moderately to severely active Crohn’s disease with a p19-directed antibody against interleukin-23, is now available in The Lancet medical journal. View full publication here: https://e.lilly/3AV1LtN #CrohnsDisease
-
-
Published in Clinical Cancer Research: Results from the EMBER-2 study, a preoperative window-of-opportunity study of an oral SERD in newly diagnosed ER+, HER2- #EarlyBreastCancer. See the data here: https://e.lilly/3YcuVMC #BreastCancer #BCSM #SERD
-
-
Did you know the majority of patients with psoriatic arthritis (#PsA) and axial spondyloarthritis (#axSpA) experience at least one comorbidity? Learn more about the common comorbidities associated with these conditions here: https://e.lilly/3YOhiVw #PsoriaticArthritis
-
-
Patients with psoriasis face a significantly higher risk of developing metabolic dysfunction-associated fatty liver disease (MAFLD) compared to the general population. This heightened risk highlights the importance of raising awareness about liver health within the psoriasis community. Dermatology providers should be particularly vigilant, recognizing hepatic disease as a common comorbidity among these patients. HCPs can access a free downloadable resource on psoriasis and hepatic disease here: https://e.lilly/3U7LJDa #PsoriarisAwareness #Psoriasis #Dermatology
-